mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder

Abstract Background Initiation of buprenorphine for treatment of opioid use disorder (OUD) in acute care settings improves access and outcomes, however patients who use methamphetamine are less likely to link to ongoing treatment. We describe the intervention and design from a pilot randomized contr...

Full description

Saved in:
Bibliographic Details
Main Authors: Elenore P. Bhatraju, Devin N. Kennedy, Alexander J. Gojic, Matthew Iles-Shih, Joseph O. Merrill, Jeffrey H. Samet, Kevin A. Hallgren, Judith I. Tsui
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Addiction Science & Clinical Practice
Subjects:
Online Access:https://doi.org/10.1186/s13722-025-00538-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571465644376064
author Elenore P. Bhatraju
Devin N. Kennedy
Alexander J. Gojic
Matthew Iles-Shih
Joseph O. Merrill
Jeffrey H. Samet
Kevin A. Hallgren
Judith I. Tsui
author_facet Elenore P. Bhatraju
Devin N. Kennedy
Alexander J. Gojic
Matthew Iles-Shih
Joseph O. Merrill
Jeffrey H. Samet
Kevin A. Hallgren
Judith I. Tsui
author_sort Elenore P. Bhatraju
collection DOAJ
description Abstract Background Initiation of buprenorphine for treatment of opioid use disorder (OUD) in acute care settings improves access and outcomes, however patients who use methamphetamine are less likely to link to ongoing treatment. We describe the intervention and design from a pilot randomized controlled trial of an intervention to increase linkage to and retention in outpatient buprenorphine services for patients with OUD and methamphetamine use who initiate buprenorphine in the hospital. Methods The study is a two-arm pilot randomized controlled trial (N = 40) comparing the mHealth Incentivized Adherence Plus Patient Navigation (MIAPP) intervention to treatment as usual. Development of the MIAPP intervention was guided by the information-motivation-behavioral skills model and combines financial rewards via mobile health-based adherence monitoring with the “human touch” of a patient navigator. Participants receive financial incentives for submitting videos of themselves taking buprenorphine via smartphone. The Patient Navigator reviews videos and provides treatment adherence coaching, care coordination and motivational enhancement. The intervention is introduced prior to hospital discharge and is offered for 30 days. The primary outcome is linkage to outpatient buprenorphine care within 30 days of hospital discharge. Secondary outcomes include retention on buprenorphine 90 days post discharge, hospital readmissions, and past 30-day methamphetamine use. Discussion Interventions are needed to increase linkage and retention to outpatient buprenorphine among hospitalized patients with OUD, especially for people who co-use methamphetamine. We will examine the MIAPP intervention to improve buprenorphine adherence and linkage to outpatient treatment in a pilot randomized controlled trial which will provide valuable insights about research approaches for hospitalized patients with substance use disorder. Trial registration number: NCT06027814. Date of Initial Release: 08/30/2023. Protocol Version: 03/21/2024.
format Article
id doaj-art-a39013005263416a87e3968166648a80
institution Kabale University
issn 1940-0640
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Addiction Science & Clinical Practice
spelling doaj-art-a39013005263416a87e3968166648a802025-02-02T12:35:55ZengBMCAddiction Science & Clinical Practice1940-06402025-01-0120111110.1186/s13722-025-00538-1mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorderElenore P. Bhatraju0Devin N. Kennedy1Alexander J. Gojic2Matthew Iles-Shih3Joseph O. Merrill4Jeffrey H. Samet5Kevin A. Hallgren6Judith I. Tsui7Department of Medicine, Division of General Internal Medicine, University of Washington/Harborview Medical CenterDepartment of Medicine, Division of General Internal Medicine, University of Washington/Harborview Medical CenterDepartment of Medicine, Division of General Internal Medicine, University of Washington/Harborview Medical CenterDepartment of Psychiatry and Behavioral Sciences, University of WashingtonDepartment of Medicine, Division of General Internal Medicine, University of Washington/Harborview Medical CenterClinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical CenterDepartment of Psychiatry and Behavioral Sciences, University of WashingtonDepartment of Medicine, Division of General Internal Medicine, University of Washington/Harborview Medical CenterAbstract Background Initiation of buprenorphine for treatment of opioid use disorder (OUD) in acute care settings improves access and outcomes, however patients who use methamphetamine are less likely to link to ongoing treatment. We describe the intervention and design from a pilot randomized controlled trial of an intervention to increase linkage to and retention in outpatient buprenorphine services for patients with OUD and methamphetamine use who initiate buprenorphine in the hospital. Methods The study is a two-arm pilot randomized controlled trial (N = 40) comparing the mHealth Incentivized Adherence Plus Patient Navigation (MIAPP) intervention to treatment as usual. Development of the MIAPP intervention was guided by the information-motivation-behavioral skills model and combines financial rewards via mobile health-based adherence monitoring with the “human touch” of a patient navigator. Participants receive financial incentives for submitting videos of themselves taking buprenorphine via smartphone. The Patient Navigator reviews videos and provides treatment adherence coaching, care coordination and motivational enhancement. The intervention is introduced prior to hospital discharge and is offered for 30 days. The primary outcome is linkage to outpatient buprenorphine care within 30 days of hospital discharge. Secondary outcomes include retention on buprenorphine 90 days post discharge, hospital readmissions, and past 30-day methamphetamine use. Discussion Interventions are needed to increase linkage and retention to outpatient buprenorphine among hospitalized patients with OUD, especially for people who co-use methamphetamine. We will examine the MIAPP intervention to improve buprenorphine adherence and linkage to outpatient treatment in a pilot randomized controlled trial which will provide valuable insights about research approaches for hospitalized patients with substance use disorder. Trial registration number: NCT06027814. Date of Initial Release: 08/30/2023. Protocol Version: 03/21/2024.https://doi.org/10.1186/s13722-025-00538-1BuprenorphineOpioid related disordersMobile Health (mHealth)Video directly observed therapyMethamphetamine use
spellingShingle Elenore P. Bhatraju
Devin N. Kennedy
Alexander J. Gojic
Matthew Iles-Shih
Joseph O. Merrill
Jeffrey H. Samet
Kevin A. Hallgren
Judith I. Tsui
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
Addiction Science & Clinical Practice
Buprenorphine
Opioid related disorders
Mobile Health (mHealth)
Video directly observed therapy
Methamphetamine use
title mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
title_full mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
title_fullStr mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
title_full_unstemmed mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
title_short mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
title_sort mhealth incentivized adherence plus patient navigation miapp protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
topic Buprenorphine
Opioid related disorders
Mobile Health (mHealth)
Video directly observed therapy
Methamphetamine use
url https://doi.org/10.1186/s13722-025-00538-1
work_keys_str_mv AT elenorepbhatraju mhealthincentivizedadherencepluspatientnavigationmiappprotocolforapilotrandomizedcontrolledtrialtoimprovelinkageandretentiononbuprenorphineforhospitalizedpatientswithmethamphetamineuseandopioidusedisorder
AT devinnkennedy mhealthincentivizedadherencepluspatientnavigationmiappprotocolforapilotrandomizedcontrolledtrialtoimprovelinkageandretentiononbuprenorphineforhospitalizedpatientswithmethamphetamineuseandopioidusedisorder
AT alexanderjgojic mhealthincentivizedadherencepluspatientnavigationmiappprotocolforapilotrandomizedcontrolledtrialtoimprovelinkageandretentiononbuprenorphineforhospitalizedpatientswithmethamphetamineuseandopioidusedisorder
AT matthewilesshih mhealthincentivizedadherencepluspatientnavigationmiappprotocolforapilotrandomizedcontrolledtrialtoimprovelinkageandretentiononbuprenorphineforhospitalizedpatientswithmethamphetamineuseandopioidusedisorder
AT josephomerrill mhealthincentivizedadherencepluspatientnavigationmiappprotocolforapilotrandomizedcontrolledtrialtoimprovelinkageandretentiononbuprenorphineforhospitalizedpatientswithmethamphetamineuseandopioidusedisorder
AT jeffreyhsamet mhealthincentivizedadherencepluspatientnavigationmiappprotocolforapilotrandomizedcontrolledtrialtoimprovelinkageandretentiononbuprenorphineforhospitalizedpatientswithmethamphetamineuseandopioidusedisorder
AT kevinahallgren mhealthincentivizedadherencepluspatientnavigationmiappprotocolforapilotrandomizedcontrolledtrialtoimprovelinkageandretentiononbuprenorphineforhospitalizedpatientswithmethamphetamineuseandopioidusedisorder
AT judithitsui mhealthincentivizedadherencepluspatientnavigationmiappprotocolforapilotrandomizedcontrolledtrialtoimprovelinkageandretentiononbuprenorphineforhospitalizedpatientswithmethamphetamineuseandopioidusedisorder